Total Synthesis of Sarcodictyins A and B
J. Am. Chem. Soc., Vol. 120, No. 34, 1998 8673
CDCl3) δ 193.9, 166.7, 159.4, 142.0, 139.3, 138.3, 136.5, 135.6, 134.1,
129.7, 122.8, 121.5, 115.8, 114.5, 89.4, 81.2, 50.2, 41.4, 39.0, 35.6,
33.6, 31.6, 28.9, 24.3, 24.3, 22.1, 22.0, 20.5; HRMS (FAB) calcd for
C28H37N2O5 (M + H+) 481.2702, found 481.2714; [R]25D +72.7 (c 0.4,
CHCl3).
1 H, C-5), 6.17 (d, J ) 5.9 Hz, 1 H, C-6), 5.28 (br s, 1 H, C-12), 4.79
(d, J ) 7.4 Hz, 1 H, C-14, C-8), 4.15 (q, J ) 7.6 Hz, 2 H, OCH2CH3),
4,14-4.11 (m, 1 H, C-1), 3.69 (s, 3 H, C-9′), 3.23 (s, 3 H, OCH3),
2.67 (br d, J ) 8.1 Hz, 1 H, C-10), 2.37 (br d, J ) 17.4 Hz, 1 H,
C-13), 2.03 (br d, J ) 17.4 Hz, 1 H, C-13), 1.63 (d, J ) 15.0 Hz, 1 H,
C-9), 1.62-1.60 (m, 2 H, C-9, C-18), 1.51 (s, 3 H, C-17), 1.44 (s, 3
H, C-16), 1.36-1.30 (m, 1 H, C-14), 1.26 (t, J ) 7.6 Hz, 3 H,
OCH2CH3, 0.97 (d, J ) 6.6 Hz, 3 H, C-19 or C-20), 0.93 (d, J ) 6.4
Hz, 3 H, C-19 or C-20); 13C NMR (125 MHz, CDCl3) δ 166.8, 166.7,
146.1, 139.2, 138.4, 136.4, 134.8, 134.0, 132.3, 131.1, 122.7, 121.4,
115.9, 115.6, 89.53, 81.43, 60.6, 50.1, 41.7, 38.8, 34.7, 33.6, 31.5, 28.9,
24.4, 24.3, 22.2, 22.0, 20.5, 14.1; HRMS (FAB) calcd for C30H40CsN2O6
Synthesis of Methyl Ester 57 with the Intermediacy of Acid 56.
To a solution of aldehyde 55 (14.0 mg, 0.0291 mmol, 1.0 equiv) in
tBuOH-H2O (5:1, 1.2 mL total) were added 2.0 M 2-methyl-2-butene
in THF (1 mL, 2.0 mmol, 68.7 equiv), NaH2PO4 (10.5 mg, 0.087 mmol,
2.9 equiv), and NaClO2 (15.7 mg, 0.174 mmol, 6.0 equiv) at 0 °C.
The reaction was stirred at the same temperature for 2 h, after which
an ether solution of CH2N2 (excess) was added and the reaction was
stirred for an additional 10 min at 25 °C. The excess CH2N2 was
removed by an argon stream, the reaction was extracted with ethyl
acetate (3 × 15 mL), dried over Na2SO4, and concentrated. The crude
residue was purified by flash chromatography (silica gel, 10:10:1
EtOAc-CH2Cl2-MeOH) to furnish methyl ester 57 (13.1 mg, 88%,
two steps): Rf ) 0.42 (silica gel, 10:10:1 EtOAc-CH2Cl2-MeOH);
FT-IR (neat) νmax 3410, 2960, 1711, 1637, 1435, 1384, 1269, 1155,
1048, 732 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J ) 15.6 Hz,
1 H, C-3′), 7.44 (s, 1 H, C-5′), 7.07 (s, 1 H, C-7′), 6.72 (d, J ) 9.9 Hz,
1 H, C-2), 6.55 (d, J ) 15.6 Hz, 1 H, C-2′), 6.48 (d, J ) 5.9 Hz, 1 H,
C-5), 6.17 (d, J ) 5.9 Hz, 1 H, C-6), 5.28 (br s, 1 H, C-12), 4.78 (d,
J ) 7.4 Hz, 1 H, C-8), 4.15-4.12 (m, 1 H, C-1), 3.70 (s, 3 H, OCH3),
3.69 (s, 3 H, C-9′), 3.22 (s, 3 H, OCH3), 2.67 (br d, J ) 10.8 Hz, 1 H,
C-10), 2.38 (br d, J ) 16.4 Hz, 1 H, C-13), 2.03 (br d, J ) 16.4 Hz,
1 H, C-13), 1.66-1.53 (m, 3 H, C-9, C-18), 1.51 (s, 3 H, C-17), 1.44
(s, 3 H, C-16), 1.37-1.28 (m, 1 H, C-14), 0.97 (d, J ) 6.6 Hz, 3 H,
C-19 or C-20), 0.92 (d, J ) 6.4 Hz, 3 H, C-19 or C-20); 13C NMR
(125 MHz, CDCl3) δ 167.1, 166.7, 146.4, 139.2, 138.4, 136.4, 134.9,
134.0, 132.0, 131.0, 122.7, 121.4, 115.9, 115.5, 89.6, 81.4, 51.8, 50.2,
41.7, 38.7, 34.7, 33.6, 31.5, 28.9, 24.4, 24.3, 22.2, 22.0, 20.5; HRMS
(FAB) calcd for C29H38CsN2O6 (M + Cs+) 643.1784, found 643.1762;
(M + Cs+) 657.1941, found 657.1959; [R]25 -12.0 (c 0.4, CHCl3).
D
Completion of the Synthesis of Sarcodictyin B (8). To a solution
of ethyl ester 58 (3.5 mg, 0.0067 mmol, 1.0 equiv) in 10:1 CH2Cl2-
H2O (1.1 mL) was added CSA (10.0 mg, 0.043 mmol, 6.4 equiv). The
reaction was then stirred at 25 °C for 24 h, after which triethylamine
was added and the reaction mixture was concentrated. The crude
mixture was purified by flash chromatography (silica gel, 10:10:1
EtOAc-CH2Cl2-MeOH) to yield sarcodictyin B (8) (3.0 mg, 86%)
as a white solid: Rf ) 0.32 (silica gel, 10:10:1 EtOAc-CH2Cl2-
MeOH); FT-IR (neat) νmax 3348, 2926, 2855, 1708, 1637, 1458, 1383,
1299, 1271, 1244, 1156, 1051; 1H NMR (500 MHz, CDCl3) δ 7.52 (d,
J ) 15.6 Hz, 1 H, C-3′), 7.44 (s, 1 H, C-5′), 7.08 (s, 1 H, C-7′), 6.81
(d, J ) 9.8 Hz, 1 H, C-2), 6.55 (d, J ) 15.5 Hz, 1 H, C-2′), 6.32 (d,
J ) 5.8 Hz, 1 H, C-5 or C-6), 6.09 (d, J ) 5.8 Hz, 1 H, C-5 or C-6),
5.30 (br s, 1 H, C-12), 4.80 (d, J ) 7.4 Hz, 1 H, C-8), 4.24-4.15 (m,
3 H, C-1 and OCH2CH3), 4.04 (s, 1 H, OH), 3.69 (s, 3 H, N-CH3),
2.71 (br d, J ) 11.7 Hz, 1 H, C-10), 2.37 (br d, J ) 11.0 Hz, 1 H,
C-13), 2.05 (br d, J ) 11.3 Hz, 1 H, C-13), 1.65 (d, J ) 14.7 Hz, 1 H,
C-9), 1.64-1.55 (m, 2 H, C-9, C-18), 1.52 (s, 3 H, C-17), 1.49 (s, 3
H, C-16), 1.28 (t, J ) 7.0 Hz, 3 H, OCH2CH3), 1.23-1.21 (m, 1 H,
C-14), 0.98 (d, J ) 6.6 Hz, 3 H, C-19 or C-20), 0.93 (d, J ) 6.4 Hz,
3 H, C-19 or C-20); 13C NMR (125 MHz, CDCl3) δ 167.8, 166.7, 147.0,
139.2, 138.4, 136.5, 134.1, 133.2, 132.8, 131.9, 122.7, 121.4, 115.9,
111.0, 90.9, 81.1, 61.1, 41.8, 39.1, 35.0, 33.6, 31.8, 28.9, 25.6, 24.4,
22.2, 22.1, 20.5, 14.1; HRMS (FAB) calcd for C29H38CsN2O6 (M +
[R]25 -44.7 (c 0.5, CHCl3).
D
Completion of the Synthesis for Sarcodictyin A (7). To a solution
of methyl ester 57 (6.0 mg, 0.0117 mmol, 1.0 equiv) in 10:1 CH2Cl2-
H2O (1.1 mL) was added CSA (10 mg, 0.043 mmol, 6.4 equiv) and
the reaction was stirred at 25 °C for 16 h, after which triethylamine
was added and the reaction mixture was concentrated. The crude
mixture was purified by flash chromatography (silica gel, 10:10:1,
EtOAc-CH2Cl2-MeOH) to yield sarcodictyin A (7) (4.6 mg, 79%)
as a white solid: Rf ) 0.32 (silica gel, 10:10:1, EtOAc-CH2Cl2-
MeOH); FT-IR (neat) νmax 2958, 2361, 1711, 1636, 1244, 1153, 1050
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J ) 16.0 Hz, 1 H, C-3′),
7.43 (s, 1 H, C-5′), 7.07 (s, 1 H, C-7′), 6.80 (d, J ) 15.6 Hz, 1 H,
C-5′), 6.33 (d, J ) 5.6 Hz, 1 H, C-5 or C-6), 6.09 (d, J ) 5.6 Hz, 1 H,
C-5 or C-6), 5.30 (br s, 1 H, C-12), 4.79 (d, J ) 7.3 Hz, 1 H, C-8),
4.20-4.17 (m, 1 H, C-1), 4.03 (s, 1 H, OH), 3.74 (s, 3 H, OCH3), 3.68
(s, 3 H, OCH3), 2.71 (d, J ) 9.9 Hz, 1 H, C-10), 2.37 (br d, J ) 16.4
Hz, 1 H, C-13), 2.05 (br d, J ) 17.2 Hz, 1 H, C-13), 1.68-1.55 (m, 3
H, C-9, C-18), 1.52 (s, 3 H, C-17), 1.48 (s, 3 H, C-16), 1.35-1.30 (m,
1 H, C-14), 0.98 (d, J ) 6.7 Hz, 3 H, C-19 or C-20), 0.92 (d, J ) 6.4
Hz, 3 H, C-19 or C-20); 13C NMR (125 MHz, CDCl3) δ 168.1, 166.7,
147.2, 139.2, 138.4, 136.5, 134.1, 133.3, 132.8, 131.8, 122.7, 121.4,
115.8, 110.9, 90.8, 81.0, 52.1, 41.8, 39.0, 35.0, 33.6, 31.8, 28.9, 25.6,
24.4, 22.2, 22.0, 20.5; HRMS (FAB) calcd for C28H36CsN2O6 (M +
Cs+) 643.1784, found 643.1804; [R]25 -4.0 (c 0.15, EtOH).
D
Synthesis of C5,C6-Saturated Analogue 61. Analogue 61 was
synthesized by the same reaction sequence followed for the two natural
products (53, 54, 55, 56, 57, 58) from alcohol 43: Rf ) 0.32 (silica
gel, 10:10:1, EtOAc-CH2Cl2-MeOH); FT-IR (neat) νmax 2959, 1711,
1
1638, 1451, 1247, 1159, 1043 cm-1; H NMR (500 MHz, CDCl3) δ
7.52 (d, J ) 15.6 Hz, 1 H), 7.45 (s, 1 H), 7.07 (s, 1 H), 6.77 (d, J )
10.2 Hz, 1 H), 6.51 (d, J ) 5.6 Hz, 1 H), 5.34 (br s, 1 H, C-12), 4.64
(d, J ) 8.0 Hz, 1 H, C-8), 4.11 (m, 1 H, C-1), 3.70 (s, 3 H, CO2Me),
3.69 (s, 3 H, N-Me), 3.20 (s, 3 H, OMe), 2.62-2.53 (m, 2 H, C-10,
C-5 or C-6), 2.49 (m, 1 H, C-5 or C-6), 2.35 (br dd, J ) 16.5, 2.0 Hz,
1 H, C-13), 2.20 (m, 1 H, C-5 or C-6), 2.06 (br dd, J ) 18.7, 2.0 Hz,
1 H, C-13), 1.82-1.75 (m, 2 H, C-5 or C-6, C-9), 1.56 (s, 3 H, Me),
1.55-1.46 (m, 1 H, C-9), 1.35 (s, 3 H, Me), 20 (m, 1 H, C-14), 0.95
(d, J ) 6.6 Hz, 3 H, C-19 or C-20), 0.92 (d, J ) 6.4 Hz, 3 H, C-19 or
C-20); 13C NMR (125 MHz, CDCl3) δ 167.5, 166.8, 148.0, 139.1, 138.4,
136.1, 133.9, 132.7, 122.6, 121.6, 116.3, 112.0, 85.4, 80.9, 51.8, 50.4,
42.4, 39.5, 37.9, 34.9, 33.6, 32.1, 30.6, 28.6, 28.1, 24.1, 22.1, 22.1,
20.6; HRMS (FAB) calcd for C29H40CsN2O6 (M + Cs+) 645.1941,
Cs+) 629.1628, found 629.1648; [R]25 -19.1 (c 0.11, EtOH).
D
found 645.1962; [ga]25 +41.7 (c 0.2, CHCl3).
D
Synthesis of Ethyl Ester 58. To a solution of aldehyde 55 (27.8
t
mg, 0.058 mmol, 1.0 equiv) in BuOH-H2O (5:1, 1.2 mL total) were
Acknowledgment. This work was supported by The Skaggs
Institute for Chemical Biology, the National Institutes of Health
USA, Novartis and CaP CURE, and by fellowships from
Novartis (to D.V.), the Japanese Society for the Promotion of
Science for Young Scientists (to S.H.), and the Department of
Defense, USA (to J.P.)
added 2.0 M 2-methyl-2-butene in THF (1 mL, 2.0 mmol, 34.4 equiv),
NaH2PO4 (20.9 mg, 0.174 mmol, 3.0 equiv) and NaClO2 (31.5 mg,
0.340 mmol, 2.9 equiv) at 0 °C. The reaction was stirred at the same
temperature for 2 h, after which an ether solution of excess CH3CHN2
was added and the reaction was stirred for an additional 10 min at 25
°C. The excess CH3CHN2 was removed by an argon stream, and the
reaction mixture was extracted with ether (2 × 15 mL), dried over
Na2SO4, and concentrated. The crude residue was purified by flash
chromatography (silica gel, 10:10:1 EtOAc-CH2Cl2-MeOH) to yield
ethyl ester 58 (27.0 mg, 89%, two steps); Rf ) 0.41 (silica gel, 10:10:1
EtOAc-CH2Cl2-MeOH); FT-IR (neat) νmax 2963, 1708, 1636, 1269,
Supporting Information Available: Selected physical data
for intermediates 10-13 (5 pages, print/PDF). See any current
masthead page for ordering information and Web access
instructions.
1
1154, 1048 cm-1; H NMR (500 MHz, CDCl3) δ 7.52 (d, J ) 15.6
Hz, 1 H, C-3′), 7.44 (s, 1 H, C-5′), 7.08 (s, 1 H, C-7′), 6.72 (d, J ) 9.8
Hz, 1 H, C-2), 6.56 (d, J ) 15.6 Hz, 1 H, C-2′), 6.49 (d, J ) 5.9 Hz,
JA981062G